These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12416786)

  • 1. Cardiorenal differences among NSAIDs and coxibs: real-world experience.
    Sonnenblick EH
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S369-70. PubMed ID: 12416786
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is there a future for COX-2 inhibitors?].
    Yodfat Y
    Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal outcomes: evidence for risk reduction in patients using coxibs.
    Scheiman JM
    Am J Manag Care; 2002 Nov; 8(17 Suppl):S518-28. PubMed ID: 12458821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of cardiovascular events with coxibs and NSAIDs.
    Scott DG; Watts RA
    Lancet; 2005 Apr 30-May 6; 365(9470):1537. PubMed ID: 15866299
    [No Abstract]   [Full Text] [Related]  

  • 8. [Migraine, juvenile rheumatoid arthritis, prevention of cancer. Potential of coxibs has not been exhausted].
    MMW Fortschr Med; 2004 Apr; 146(17):57. PubMed ID: 15224911
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment on Jüni P, Dieppe P. Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs.
    Stichtenoth DO; Frölich JC
    Age Ageing; 2004 Sep; 33(5):521. PubMed ID: 15315931
    [No Abstract]   [Full Text] [Related]  

  • 10. Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease.
    LeLorier J; Bombardier C; Burgess E; Moist L; Wright N; Cartier P; Huckell V; Hunt R; Nawar T; Tobe S
    Can J Cardiol; 2002 Dec; 18(12):1301-8. PubMed ID: 12518182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older people should NOT be prescribed 'coxibs' in place of conventional NSAIDs.
    Jüni P; Dieppe P
    Age Ageing; 2004 Mar; 33(2):100-4. PubMed ID: 14960422
    [No Abstract]   [Full Text] [Related]  

  • 12. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alleviating pain and preventing inflammation with selective COX-2 inhibitors. Prescribing with confidence in the future].
    MMW Fortschr Med; 2005 Mar; 147(9):12. PubMed ID: 15794346
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effective use of NSAIDs: issues pertinent to coxib use in managed care.
    Fendrick AM
    Am J Manag Care; 2002 Nov; 8(17 Suppl):S529-41. PubMed ID: 12458822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs.
    Mitchell JA; Warner TD
    Nat Rev Drug Discov; 2006 Jan; 5(1):75-86. PubMed ID: 16485347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Celecoxib].
    Fux R; Mörike K; Gleiter CH
    Dtsch Med Wochenschr; 2002 Apr; 127(15):803-4. PubMed ID: 11951138
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular adverse effects of coxibs.
    Prescrire Int; 2002 Dec; 11(62):181-2. PubMed ID: 12472094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAIDs, including coxibs, probably do more harm than good, and paracetamol is ineffective for hip OA.
    Bjordal JM; Ljunggren AE; Klovning A; Slørdal L
    Ann Rheum Dis; 2005 Apr; 64(4):655-6; author reply 656. PubMed ID: 15769931
    [No Abstract]   [Full Text] [Related]  

  • 19. Pain killers--bane or boon? (NSAIDs or COXIBs).
    Joshi SR; Nadkar MY
    J Assoc Physicians India; 2005 Jul; 53():591-2. PubMed ID: 16190125
    [No Abstract]   [Full Text] [Related]  

  • 20. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
    Tannenbaum H; Bombardier C; Davis P; Russell AS;
    J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.